Halifax-based Sona Nanotech, which makes rapid diagnostic tests, has been granted regulatory approval to sell its rapid test for COVID-19 in the European Union.
The company said in a statement New Year’s Eve that its rapid, COVID-19 antigen test had received CE Mark status, meaning the test kits can be sold in the EU and other territories where the CE Mark is recognized. The tests can produce results in 15 minutes, it said in a statement.
The company’s shares – which have undergone tremendous gains and losses in the last year – surged on the news of the regulatory approval before settling